Roche Holding AG Overview
Latest ROE for Roche Holding AG: 66.85% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow66.85%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for RHHBF is 66.85%. That is above the Healthcare sector average of 22.13%. Investors often review this figure alongside Roche Holding AG's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, RHHBF currently prints 66.85% for ROE, while the sector average sits near 22.13%. That is roughly 202.1% above the sector mean. Large gaps often invite a closer look at Roche Holding AG's growth, margins, and balance sheet.
Return on Equity shows how effectively Roche Holding AG converts resources into returns. At 66.85%, RHHBF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting RHHBF's ROE (66.85%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Roche Holding AG's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
